Gastrointestinal Complications Associated with Hepatic Arterial Yttrium-90 Microsphere Therapy
Ravi Murthy(The University of Texas MD Anderson Cancer Center), Michael L. Censullo(Memorial Hermann), Douglas M. Coldwell(University of Mississippi), Sunil Krishnan(Smith Family), Amit Habbu(The University of Texas MD Anderson Cancer Center), Riad Salem(Northwestern University), David Liu(Bristol-Myers Squibb (Germany)), William A. Ross, Alan M. Cohen, Steven G. Meranze(Vanderbilt University Medical Center), Rodolfo Núñez(The University of Texas MD Anderson Cancer Center), Daniel B. Brown
Cited by 163
Related Papers
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k
Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes
|Gastroenterology|2009|1.1k
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Proposal of a New Adverse Event Classification by the Society of Interventional Radiology Standards of Practice Committee
|Journal of Vascular and Interventional Radiology|2017|701